Search research articles
Contact Us
Filters
Showing results (261-270 of 459) with videos related to
Page
of 46
Sort By:
Expert Opinion on Investigational Drugs
|
March 10, 2015
Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer
Matteo Santoni, Francesco Massari, Marzia Del Re, et al.
Immunotherapy
|
April 28, 2021
Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: a meta-analysis
Alessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
Communications Medicine
|
May 27, 2026
Microplastics as both a driver of genitourinary cancers and a deliverer of treatments
Kannan Sridharan, Brigida Anna Maiorano, Farah Rehan, et al.
Journal of Clinical Medicine
|
October 16, 2024
Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives
Samuele Compagno, Chiara Casadio, Linda Galvani, et al.
Expert Review of Molecular Diagnostics
|
October 24, 2019
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer
Veronica Mollica, Vincenzo Di Nunno, Matteo Santoni, et al.
Expert Review of Anticancer Therapy
|
March 24, 2016
Prostate cancer: from Gleason scoring to prognostic grade grouping
Rodolfo Montironi, Matteo Santoni, Roberta Mazzucchelli, et al.
Oncotarget
|
December 7, 2017
The TRPV1 ion channel regulates thymocyte differentiation by modulating autophagy and proteasome activity
Consuelo Amantini, Valerio Farfariello, Claudio Cardinali, et al.
Clinical Drug Investigation
|
April 3, 2019
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution
Veronica Mollica, Vincenzo Di Nunno, Lidia Gatto, et al.
Future Oncology (London, England)
|
August 25, 2018
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer
Vincenzo Di Nunno, Alessia Cimadamore, Matteo Santoni, et al.
Cancer Medicine
|
January 2, 2024
Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate
Ondřej Fiala, Petr Hošek, Hana Korunková, et al.
Page
of 46
Search research articles
Search
Showing results (261-270 of 459) with videos related to
Sort By:
Page
of 46
Expert Opinion on Investigational Drugs
|
March 10, 2015
Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer
Matteo Santoni, Francesco Massari, Marzia Del Re, et al.
Immunotherapy
|
April 28, 2021
Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: a meta-analysis
Alessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
Communications Medicine
|
May 27, 2026
Microplastics as both a driver of genitourinary cancers and a deliverer of treatments
Kannan Sridharan, Brigida Anna Maiorano, Farah Rehan, et al.
Journal of Clinical Medicine
|
October 16, 2024
Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives
Samuele Compagno, Chiara Casadio, Linda Galvani, et al.
Expert Review of Molecular Diagnostics
|
October 24, 2019
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer
Veronica Mollica, Vincenzo Di Nunno, Matteo Santoni, et al.
Expert Review of Anticancer Therapy
|
March 24, 2016
Prostate cancer: from Gleason scoring to prognostic grade grouping
Rodolfo Montironi, Matteo Santoni, Roberta Mazzucchelli, et al.
Oncotarget
|
December 7, 2017
The TRPV1 ion channel regulates thymocyte differentiation by modulating autophagy and proteasome activity
Consuelo Amantini, Valerio Farfariello, Claudio Cardinali, et al.
Clinical Drug Investigation
|
April 3, 2019
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution
Veronica Mollica, Vincenzo Di Nunno, Lidia Gatto, et al.
Future Oncology (London, England)
|
August 25, 2018
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer
Vincenzo Di Nunno, Alessia Cimadamore, Matteo Santoni, et al.
Cancer Medicine
|
January 2, 2024
Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate
Ondřej Fiala, Petr Hošek, Hana Korunková, et al.
Page
of 46